Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
SHG
Shinhan Financial Group Co., Ltd.
Health insurance is a significant component of SHG's insurance offerings.
|
$27.22B |
$53.27
+0.37%
|
|
DXCM
DexCom, Inc.
DexCom's core product is continuous glucose monitoring (CGM), i.e., glucose monitoring devices sold as CGM systems.
|
$26.26B |
$66.13
-1.24%
|
|
BIIB
Biogen Inc.
Biogen's LEQEMBI is an Alzheimer's disease therapeutic, a direct product the company manufactures and sells.
|
$25.77B |
$175.19
+0.63%
|
|
STE
STERIS plc
STERIS manufactures surgical equipment, including sterilizers and endoscope-related devices used in operating rooms and infection prevention.
|
$25.02B |
$254.58
+1.11%
|
|
VLTO
Veralto Corporation
Veralto may offer laboratory testing and advisory services around water quality testing and compliance.
|
$24.50B |
$99.93
+1.24%
|
|
JBL
Jabil Inc.
Aseptic filling and dry oral dosage capabilities via Pharmaceutics International (Pii) reflect contract manufacturing services in pharma.
|
$23.86B |
$222.22
-0.07%
|
|
WAT
Waters Corporation
Waters supplies diagnostic instruments used in laboratories for analytical testing and qualification workflows.
|
$22.94B |
$384.11
-0.32%
|
|
BNTX
BioNTech SE
The company is pivoting toward oncology with immunotherapies, making Biotech - Oncology a core product/business focus.
|
$22.73B |
$94.09
-0.76%
|
|
UTHR
United Therapeutics Corporation
UTHR's core PAH/CV therapy portfolio centers on prostacyclin cardiovascular drugs, including Tyvaso, Remodulin, Orenitram, and Ralinepag (where applicable).
|
$22.63B |
$497.83
+0.78%
|
|
LH
Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
|
$21.88B |
$262.34
-0.70%
|
|
GMAB
Genmab A/S
Genmab is a biotechnology company focused on oncology therapeutics, fitting Biotech - Oncology.
|
$20.89B |
$31.43
+0.40%
|
|
PODD
Insulet Corporation
Insulet's core business is medical devices and equipment, anchored by the Omnipod insulin pump platform.
|
$20.82B |
$293.04
-0.90%
|
|
ILMN
Illumina, Inc.
Sequencing instruments and related medical device equipment are Illumina's core manufactured products sold to researchers and clinical labs.
|
$20.73B |
$134.63
-0.18%
|
|
CHD
Church & Dwight Co., Inc.
Waterpik dental water flossers and related oral-care devices are dental equipment products.
|
$20.61B |
$85.00
+0.46%
|
|
DGX
Quest Diagnostics Incorporated
Quest provides laboratory testing services and advisory/regulatory support for microbiology and analytical workflows.
|
$20.41B |
$183.96
+0.76%
|
|
CNC
Centene Corporation
Centene's core business is providing health insurance (Medicaid/Medicare and Marketplace) via managed care programs, making Health Insurance its direct product/service.
|
$20.06B |
$40.88
+0.09%
|
|
WST
West Pharmaceutical Services, Inc.
West generates revenue from contract manufacturing services, moving towards higher-margin opportunities.
|
$19.24B |
$271.90
+1.62%
|
|
EXAS
Exact Sciences Corporation
Oncotype DX is a genomic assay used as a companion diagnostic in oncology, and the company discusses companion diagnostic capabilities and leadership in Precision Oncology.
|
$19.22B |
$101.56
+0.06%
|
|
INCY
Incyte Corporation
Incyte's business is centered on oncology-focused therapeutics, including Monjuvi and a broad cancer pipeline.
|
$18.63B |
$98.14
+2.87%
|
|
SNA
Snap-on Incorporated
RS&I segment includes diagnostic equipment and repair information software platforms.
|
$18.30B |
$352.37
+0.44%
|
|
ZBH
Zimmer Biomet Holdings, Inc.
Zimmer Biomet's core orthopedic devices business centers on joint implants (hips and knees) and related prosthetics.
|
$18.14B |
$92.46
+0.95%
|
|
THC
Tenet Healthcare Corporation
Tenet operates hospitals and hospital-based care delivering inpatient and outpatient services.
|
$17.62B |
$197.76
-0.82%
|
|
HOLX
Hologic, Inc.
Panther Panther Fusion molecular diagnostics platform and Aptima/BV/CV/TV assays are diagnostic equipment sold by Hologic.
|
$16.68B |
$75.14
+0.19%
|
|
COO
The Cooper Companies, Inc.
CooperVision and CooperSurgical primarily manufacture ophthalmology devices and related vision-care products, fitting Ophthalmology Devices.
|
$16.32B |
$81.04
-1.27%
|
|
IFF
International Flavors & Fragrances Inc.
DEB and enzyme-based biotechnologies are core to IFF's Health & Biosciences innovation and product offerings.
|
$16.21B |
$64.02
+1.19%
|
|
BWXT
BWX Technologies, Inc.
Radiopharmaceuticals for nuclear medicine imaging and diagnostics.
|
$15.94B |
$173.75
-0.73%
|
|
MEDP
Medpace Holdings, Inc.
Medpace's core business is a specialized full-service CRO delivering Phase I–IV clinical development services.
|
$15.67B |
$559.87
+0.35%
|
|
ULS
UL Solutions Inc.
UL Solutions offers Laboratory Testing & Advisory Services, including regulatory advisory and compliance support.
|
$15.64B |
$77.20
-0.87%
|
|
ICLR
ICON Public Limited Company
Directly describes ICON's outsourced drug development and management services as a Contract Research Organization.
|
$15.40B |
$184.52
-1.10%
|
|
NBIX
Neurocrine Biosciences, Inc.
Neurocrine's core focus is neuroscience with programs in neuropsychiatric disorders (MDD, schizophrenia, TD) and related CNS conditions.
|
$15.15B |
$153.16
+0.23%
|
|
ROIV
Roivant Sciences Ltd.
Immunovant's FcRn-targeting therapies (e.g., IMVT-1402, batoclimab) are monoclonal antibody therapeutics.
|
$15.09B |
$21.73
-1.70%
|
|
RVMD
Revolution Medicines, Inc.
Clinical-stage biotech focused on oncology; primary products are RAS(ON) inhibitors for cancer.
|
$14.75B |
$79.67
+0.94%
|
Showing page 4 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
